Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial

被引:3
|
作者
Lindkvist, Emilie Bundgaard [1 ,2 ]
Laugesen, Christian [1 ,2 ]
Reenberg, Asbjorn Thode [3 ]
Ritschel, Tobias Kasper Skov [3 ]
Svensson, Jannet [1 ,4 ]
Jorgensen, John Bagterp [3 ]
Norgaard, Kirsten [1 ,2 ]
Ranjan, Ajenthen G. G. [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark
[4] Herlev & Gentofte Univ Hosp, Dept Pediat, Herlev, Denmark
[5] Danish Diabet Acad, Odense, Denmark
来源
关键词
type 1 diabetes mellitus; adolescents; dual-hormone; advanced hybrid closed-loop; artificial pancreas; non-linear model predictive control; moderate intensity continuous exercise; ARTIFICIAL PANCREAS; OPEN-LABEL; GLYCEMIC CONTROL; PUMP THERAPY; GLUCOSE; OUTPATIENT; PAIN;
D O I
10.3389/fendo.2023.1073388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo assess the efficacy and safety of a dual-hormone (DH [insulin and glucagon]) closed-loop system compared to a single-hormone (SH [insulin only]) closed-loop system in adolescents with type 1 diabetes. MethodsThis was a 26-hour, two-period, randomized, crossover, inpatient study involving 11 adolescents with type 1 diabetes (nine males [82%], mean +/- SD age 14.8 +/- 1.4 years, diabetes duration 5.7 +/- 2.3 years). Except for the treatment configuration of the DiaCon Artificial Pancreas: DH or SH, experimental visits were identical consisting of: an overnight stay (10:00 pm until 7:30 am), several meals/snacks, and a 45-minute bout of moderate intensity continuous exercise. The primary endpoint was percentage of time spent with sensor glucose values below range (TBR [<3.9 mmol/L]) during closed-loop control over the 26-h period (5:00 pm, day 1 to 7:00 pm, day 2). ResultsOverall, there were no differences between DH and SH for the following glycemic outcomes (median [IQR]): TBR 1.6 [0.0, 2.4] vs. 1.28 [0.16, 3.19]%, p=1.00; time in range (TIR [3.9-10.0 mmol/L]) 68.4 [48.7, 76.8] vs. 75.7 [69.8, 87.1]%, p=0.08; and time above range (TAR [>10.0 mmol/L]) 28.1 [18.1, 49.8] vs. 23.3 [12.3, 27.2]%, p=0.10. Mean ( +/- SD) glucose was higher during DH than SH (8.7 ( +/- 3.2) vs. 8.1 ( +/- 3.0) mmol/L, p<0.001) but coefficient of variation was similar (34.8 ( +/- 6.8) vs. 37.3 ( +/- 8.6)%, p=0.20). The average amount of rescue carbohydrates was similar between DH and SH (6.8 ( +/- 12.3) vs. 9.5 ( +/- 15.4) grams/participant/visit, p=0.78). Overnight, TIR was higher, TAR was lower during the SH visit compared to DH. During and after exercise (4:30 pm until 7 pm) the SH configuration produced higher TIR, but similar TAR and TBR compared to the DH configuration. ConclusionsDH and SH performed similarly in adolescents with type 1 diabetes during a 26-hour inpatient monitoring period involving several metabolic challenges including feeding and exercise. However, during the night and around exercise, the SH configuration outperformed DH.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes Reply
    Breton, Marc D.
    Beck, Roy W.
    Wadwa, R. Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2484 - 2484
  • [22] A Multicenter Evaluation of a Closed-Loop Anesthesia Delivery System: A Randomized Controlled Trial
    Puri, Goverdhan D.
    Mathew, Preethy J.
    Biswas, Indranil
    Dutta, Amitabh
    Sood, Jayashree
    Gombar, Satinder
    Palta, Sanjeev
    Tsering, Morup
    Gautam, P. L.
    Jayant, Aveek
    Arora, Inderjeet
    Bajaj, Vishal
    Punia, T. S.
    Singh, Gurjit
    ANESTHESIA AND ANALGESIA, 2016, 122 (01): : 106 - 114
  • [23] A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes
    Allan L. Reiss
    Booil Jo
    Ana Maria Arbelaez
    Eva Tsalikian
    Bruce Buckingham
    Stuart A. Weinzimer
    Larry A. Fox
    Allison Cato
    Neil H. White
    Michael Tansey
    Tandy Aye
    William Tamborlane
    Kimberly Englert
    John Lum
    Paul Mazaika
    Lara Foland-Ross
    Matthew Marzelli
    Nelly Mauras
    Nature Communications, 13
  • [24] Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton, C. K.
    Hovorka, R.
    DIABETIC MEDICINE, 2019, 36 (03) : 279 - 286
  • [25] A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes
    Reissetz, Allan L.
    Jo, Booil
    Foland-Ross, Lara
    Marzelli, Matthew
    Mazaika, Paul
    Tong, Gabby
    Shen, Hanyang
    Li, Zetan
    Buckingham, Bruce
    Aye, Tandy
    Kingman, Ryan
    White, Neil H.
    Arbelaez, Ana Maria
    Levandoski, Lucy
    Tsalikian, Eva
    Tansey, Michael
    Coffey, Julie
    Bisbee, Rachel
    WeinzimerO, Stuart A.
    Tamborlane, William
    Stephen, Amy
    Weyman, Kate
    Mauras, Nelly
    Fox, Larry A.
    Englen, Kimberly
    Bird, Keisha
    Ponthieux, Kimberly
    Marrero, Juan
    Cato, Allison
    Lum, John
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [26] A Randomized Crossover Trial Comparing Glucose Control between Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop System
    Seckold, Rowen
    Morrison, Dale
    Rafferty, Jordan
    Valkenborghs, Sarah R.
    Paldus, Barbora
    Zaharieva, Dessi P.
    Riddell, Michael C.
    Smart, Carmel E.
    O'Neal, David N.
    King, Bruce R.
    DIABETES, 2023, 72
  • [27] Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes A Randomized Clinical Trial
    Abraham, Mary B.
    de Bock, Martin
    Smith, Grant J.
    Dart, Julie
    Fairchild, Janice M.
    King, Bruce R.
    Ambler, Geoffrey R.
    Cameron, Fergus J.
    McAuley, Sybil A.
    Keech, Anthony C.
    Jenkins, Alicia
    Davis, Elizabeth A.
    O'Neal, David N.
    Jones, Timothy W.
    JAMA PEDIATRICS, 2021, 175 (12) : 1227 - 1235
  • [28] Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
    Stewart, Zoe A.
    Wilinska, Malgorzata E.
    Hartnell, Sara
    O'Neil, Leanne K.
    Rayman, Gerry
    Scott, Eleanor M.
    Barnard, Katharine
    Farrington, Conor
    Hovorka, Roman
    Murphy, Helen R.
    DIABETES CARE, 2018, 41 (07) : 1391 - 1399
  • [29] CAN DUAL-HORMONE CLOSED-LOOP DELIVERY ALLEVIATE THE BURDEN OF CARBOHYDRATE COUNTING FROM PATIENTS WITH TYPE 1 DIABETES?
    Farid, D.
    St-Yves, A.
    Rabasa-Lhoret, R.
    Duval, C.
    Messier, V.
    Brazeau, A. -S.
    Boulet, B.
    Legault, L.
    Haidar, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A95 - A95
  • [30] Closed-Loop Insulin Therapy in Patients with Type-1-Diabetes Large, randomized, multicenter Trial
    Schellinger, Isabel N.
    DIABETOLOGE, 2020, 16 (02): : 186 - 187